-
1
-
-
62149144052
-
Allergic bronchopulmonary aspergillosis
-
Agarwal R. Allergic bronchopulmonary aspergillosis. Chest 135(3), 805-826 (2009)
-
(2009)
Chest
, vol.135
, Issue.3
, pp. 805-826
-
-
Agarwal, R.1
-
2
-
-
84855227890
-
Allergic bronchopulmonary aspergillosis
-
Jindal SK, Shankar PS, Raoof S, Gupta D, Aggarwal AN, Agarwal R (Eds Jaypee Publications, New Delhi, India
-
Agarwal R. Allergic bronchopulmonary aspergillosis. In: Textbook of Pulmonary and Critical Care Medicine. Jindal SK, Shankar PS, Raoof S, Gupta D, Aggarwal AN, Agarwal R (Eds). Jaypee Publications, New Delhi, India, 947-970 (2010)
-
(2010)
Textbook of Pulmonary and Critical Care Medicine
, vol.947-970
-
-
Agarwal, R.1
-
3
-
-
84861188581
-
Serologic allergic bronchopulmonary aspergillosis (ABPA-S): Long-term outcomes
-
Agarwal R, Garg M, Aggarwal AN, Saikia B, Gupta D, Chakrabarti A. Serologic allergic bronchopulmonary aspergillosis (ABPA-S): Long-term outcomes. Respir. Med. 106(7), 942-947 (2012)
-
(2012)
Respir. Med.
, vol.106
, Issue.7
, pp. 942-947
-
-
Agarwal, R.1
Garg, M.2
Aggarwal, A.N.3
Saikia, B.4
Gupta, D.5
Chakrabarti, A.6
-
4
-
-
62149132492
-
Pulmonary hypertension as a presenting manifestation of allergic bronchopulmonary aspergillosis
-
Agarwal R, Singh N, Gupta D. Pulmonary hypertension as a presenting manifestation of allergic bronchopulmonary aspergillosis. Indian J. Chest Dis. Allied Sci. 51(1), 37-40 (2009)
-
(2009)
Indian J. Chest Dis. Allied Sci.
, vol.51
, Issue.1
, pp. 37-40
-
-
Agarwal, R.1
Singh, N.2
Gupta, D.3
-
5
-
-
32644447957
-
The link between fungi and severe asthma: A summary of the evidence
-
Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: A summary of the evidence. Eur. Respir. J. 27(3), 615-626 (2006)
-
(2006)
Eur. Respir. J.
, vol.27
, Issue.3
, pp. 615-626
-
-
Denning, D.W.1
O'Driscoll, B.R.2
Hogaboam, C.M.3
Bowyer, P.4
Niven, R.M.5
-
6
-
-
58349115630
-
Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study
-
Denning DW, O'Driscoll BR, Powell G et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am. J. Respir. Crit. Care Med. 179(1), 11-18 (2009)
-
(2009)
Am. J. Respir. Crit. Care Med.
, vol.179
, Issue.1
, pp. 11-18
-
-
Denning, D.W.1
O'Driscoll, B.R.2
Powell, G.3
-
7
-
-
81055157067
-
Severe asthma with fungal sensitization
-
Agarwal R. Severe asthma with fungal sensitization. Curr. Allergy Asthma Rep. 11(5), 403-413 (2011)
-
(2011)
Curr. Allergy Asthma Rep.
, vol.11
, Issue.5
, pp. 403-413
-
-
Agarwal, R.1
-
8
-
-
79952669906
-
Severe asthma and fungi: Current evidence
-
Agarwal R, Gupta D. Severe asthma and fungi: Current evidence. Med. Mycol. 49(SUPPL.1), S150-S157 (2011)
-
(2011)
Med. Mycol.
, vol.49
, Issue.SUPPL. 1
-
-
Agarwal, R.1
Gupta, D.2
-
9
-
-
33747613125
-
Allergic bronchopulmonary aspergillosis: Lessons from 126 patients attending a chest clinic in north India
-
Agarwal R, Gupta D, Aggarwal AN, Behera D, Jindal SK. Allergic bronchopulmonary aspergillosis: Lessons from 126 patients attending a chest clinic in north India. Chest 130(2), 442-448 (2006)
-
(2006)
Chest
, vol.130
, Issue.2
, pp. 442-448
-
-
Agarwal, R.1
Gupta, D.2
Aggarwal, A.N.3
Behera, D.4
Jindal, S.K.5
-
10
-
-
35448968896
-
Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: An analysis of 155 patients
-
Agarwal R, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A, Jindal SK. Clinical significance of hyperattenuating mucoid impaction in allergic bronchopulmonary aspergillosis: An analysis of 155 patients. Chest 132(4), 1183-1190 (2007)
-
(2007)
Chest
, vol.132
, Issue.4
, pp. 1183-1190
-
-
Agarwal, R.1
Gupta, D.2
Aggarwal, A.N.3
Saxena, A.K.4
Chakrabarti, A.5
Jindal, S.K.6
-
11
-
-
73749088045
-
Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis
-
Agarwal R, Gupta D, Aggarwal AN et al. Clinical significance of decline in serum IgE levels in allergic bronchopulmonary aspergillosis. Respir. Med. 104(2), 204-210 (2010)
-
(2010)
Respir. Med.
, vol.104
, Issue.2
, pp. 204-210
-
-
Agarwal, R.1
Gupta, D.2
Aggarwal, A.N.3
-
12
-
-
78650740724
-
An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus
-
Agarwal R, Khan A, Gupta D, Aggarwal AN, Saxena AK, Chakrabarti A. An alternate method of classifying allergic bronchopulmonary aspergillosis based on high-attenuation mucus. PLoS ONE 5(12), e15346 (2010)
-
(2010)
PLoS ONE
, vol.5
, Issue.12
-
-
Agarwal, R.1
Khan, A.2
Gupta, D.3
Aggarwal, A.N.4
Saxena, A.K.5
Chakrabarti, A.6
-
13
-
-
84941815348
-
Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies
-
Patterson R, Greenberger PA, Halwig JM, Liotta JL, Roberts M. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch. Intern. Med. 146(5), 916-918 (1986)
-
(1986)
Arch. Intern. Med.
, vol.146
, Issue.5
, pp. 916-918
-
-
Patterson, R.1
Greenberger, P.A.2
Halwig, J.M.3
Liotta, J.L.4
Roberts, M.5
-
14
-
-
0030426743
-
An overview of the adverse reactions to adrenal corticosteroids
-
Frauman AG. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React. Toxicol. Rev. 15(4), 203-206 (1996)
-
(1996)
Adverse Drug React. Toxicol. Rev.
, vol.15
, Issue.4
, pp. 203-206
-
-
Frauman, A.G.1
-
15
-
-
0036810356
-
Mechanisms involved in the side effects of glucocorticoids
-
Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol. Ther. 96(1), 23-43 (2002)
-
(2002)
Pharmacol. Ther.
, vol.96
, Issue.1
, pp. 23-43
-
-
Schacke, H.1
Docke, W.D.2
Asadullah, K.3
-
16
-
-
0024083933
-
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987
-
De Beule K, De Doncker P, Cauwenbergh G et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 31(9), 476-485 (1988)
-
(1988)
Mycoses
, vol.31
, Issue.9
, pp. 476-485
-
-
De Beule, K.1
De Doncker, P.2
Cauwenbergh, G.3
-
17
-
-
0026070141
-
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole
-
Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 100(3), 813-819 (1991)
-
(1991)
Chest
, vol.100
, Issue.3
, pp. 813-819
-
-
Denning, D.W.1
Van Wye, J.E.2
Lewiston, N.J.3
Stevens, D.A.4
-
18
-
-
0028912464
-
Allergic bronchopulmonary aspergillosis treated with itraconazole
-
Germaud P, Tuchais E. Allergic bronchopulmonary aspergillosis treated with itraconazole. Chest 107(3), 883 (1995)
-
(1995)
Chest
, vol.107
, Issue.3
, pp. 883
-
-
Germaud, P.1
Tuchais, E.2
-
19
-
-
0005671362
-
Allergic bronchopulmonary aspergillosis in cystic fibrosis: Role of atopy and response to itraconazole
-
Nepomuceno IB, Esrig S, Moss RB. Allergic bronchopulmonary aspergillosis in cystic fibrosis: role of atopy and response to itraconazole. Chest 115(2), 364-370 (1999)
-
(1999)
Chest
, vol.115
, Issue.2
, pp. 364-370
-
-
Nepomuceno, I.B.1
Esrig, S.2
Moss, R.B.3
-
20
-
-
0010002123
-
Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis
-
Salez F, Brichet A, Desurmont S, Grosbois JM, Wallaert B, Tonnel AB. Effects of itraconazole therapy in allergic bronchopulmonary aspergillosis. Chest 116(6), 1665-1668 (1999)
-
(1999)
Chest
, vol.116
, Issue.6
, pp. 1665-1668
-
-
Salez, F.1
Brichet, A.2
Desurmont, S.3
Grosbois, J.M.4
Wallaert, B.5
Tonnel, A.B.6
-
21
-
-
0034673751
-
A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis
-
Stevens DA, Schwartz HJ, Lee JY et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N. Engl. J. Med. 342(11), 756-762 (2000)
-
(2000)
N. Engl. J. Med.
, vol.342
, Issue.11
, pp. 756-762
-
-
Stevens, D.A.1
Schwartz, H.J.2
Lee, J.Y.3
-
22
-
-
0036338121
-
Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
-
Skov M, Hoiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy 57(8), 723-728 (2002)
-
(2002)
Allergy
, vol.57
, Issue.8
, pp. 723-728
-
-
Skov, M.1
Hoiby, N.2
Koch, C.3
-
23
-
-
0038752563
-
Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomized controlled trial
-
Wark PA, Hensley MJ, Saltos N et al. Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomized controlled trial. J. Allergy Clin. Immunol. 111(5), 952-957 (2003)
-
(2003)
J. Allergy Clin. Immunol.
, vol.111
, Issue.5
, pp. 952-957
-
-
Wark, P.A.1
Hensley, M.J.2
Saltos, N.3
-
24
-
-
11144263151
-
Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment
-
Wark P. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment. Respir. Med. 98(10), 915-923 (2004)
-
(2004)
Respir. Med.
, vol.98
, Issue.10
, pp. 915-923
-
-
Wark, P.1
-
25
-
-
0025049533
-
Adverse events associated with itraconazole in 189 patients on chronic therapy
-
Tucker RM, Haq Y, Denning DW, Stevens DA. Adverse events associated with itraconazole in 189 patients on chronic therapy. J. Antimicrob. Chemother. 26(4), 561-566 (1990)
-
(1990)
J. Antimicrob. Chemother.
, vol.26
, Issue.4
, pp. 561-566
-
-
Tucker, R.M.1
Haq, Y.2
Denning, D.W.3
Stevens, D.A.4
-
26
-
-
84863005600
-
Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization
-
Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J. Asthma 49(4), 423-433 (2012)
-
(2012)
J. Asthma
, vol.49
, Issue.4
, pp. 423-433
-
-
Chishimba, L.1
Niven, R.M.2
Cooley, J.3
Denning, D.W.4
-
27
-
-
83655191230
-
Allergic bronchopulmonary aspergillosis and related allergic syndromes
-
Hogan C, Denning DW. Allergic bronchopulmonary aspergillosis and related allergic syndromes. Semin. Respir. Crit. Care Med. 32(6), 682-692 (2011)
-
(2011)
Semin. Respir. Crit. Care Med.
, vol.32
, Issue.6
, pp. 682-692
-
-
Hogan, C.1
Denning, D.W.2
-
28
-
-
0035037259
-
Allergic bronchopulmonary aspergillosis: New concepts of pathogenesis and treatment
-
Wark PA, Gibson PG. Allergic bronchopulmonary aspergillosis: New concepts of pathogenesis and treatment. Respirology 6(1), 1-7 (2001)
-
(2001)
Respirology
, vol.6
, Issue.1
, pp. 1-7
-
-
Wark, P.A.1
Gibson, P.G.2
-
29
-
-
84990463013
-
Allergic bronchopulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests
-
McCarthy DS, Pepys J. Allergic bronchopulmonary aspergillosis. Clinical immunology. 2. Skin, nasal and bronchial tests. Clin. Allergy 1(4), 415-432 (1971)
-
(1971)
Clin. Allergy
, vol.1
, Issue.4
, pp. 415-432
-
-
McCarthy, D.S.1
Pepys, J.2
-
30
-
-
0036411669
-
Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital
-
Chakrabarti A, Sethi S, Raman DS, Behera D. Eight-year study of allergic bronchopulmonary aspergillosis in an Indian teaching hospital. Mycoses 45(8), 295-299 (2002)
-
(2002)
Mycoses
, vol.45
, Issue.8
, pp. 295-299
-
-
Chakrabarti, A.1
Sethi, S.2
Raman, D.S.3
Behera, D.4
-
31
-
-
78649874113
-
IgE sensitisation to Aspergillus fumigatus is associated with reduced lung function in asthma
-
Fairs A, Agbetile J, Hargadon B et al. IgE sensitisation to Aspergillus fumigatus is associated with reduced lung function in asthma. Am. J. Respir. Crit. Care Med. 182(11), 1362-1368 (2010)
-
(2010)
Am. J. Respir. Crit. Care Med.
, vol.182
, Issue.11
, pp. 1362-1368
-
-
Fairs, A.1
Agbetile, J.2
Hargadon, B.3
-
32
-
-
79953869925
-
High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease
-
Denning DW, Park S, Lass-Florl C et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin. Infect. Dis. 52(9), 1123-1129 (2011)
-
(2011)
Clin. Infect. Dis.
, vol.52
, Issue.9
, pp. 1123-1129
-
-
Denning, D.W.1
Park, S.2
Lass-Florl, C.3
-
33
-
-
84859990716
-
Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV(1
-
Agbetile J, Fairs A, Desai D et al. Isolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV(1). Clin. Exp. Allergy 42(5), 782-791 (2012)
-
(2012)
Clin. Exp. Allergy
, vol.42
, Issue.5
, pp. 782-791
-
-
Agbetile, J.1
Fairs, A.2
Desai, D.3
-
34
-
-
0023255451
-
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells
-
Abruzzo GK, Fromtling RA, Turnbull TA, Giltinan DM. Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells. J. Antimicrob. Chemother. 20(1), 61-68 (1987)
-
(1987)
J. Antimicrob. Chemother.
, vol.20
, Issue.1
, pp. 61-68
-
-
Abruzzo, G.K.1
Fromtling, R.A.2
Turnbull, T.A.3
Giltinan, D.M.4
-
35
-
-
0025948260
-
The anti-fungal agent itraconazole exerts immunosuppressive effects on alloreactivity but not on natural immunity in vitro
-
Pawelec G, Jaschonek K, Ehninger G. The anti-fungal agent itraconazole exerts immunosuppressive effects on alloreactivity but not on natural immunity in vitro. Int. J. Immunopharmacol. 13(7), 875-879 (1991)
-
(1991)
Int. J. Immunopharmacol.
, vol.13
, Issue.7
, pp. 875-879
-
-
Pawelec, G.1
Jaschonek, K.2
Ehninger, G.3
-
36
-
-
0025964481
-
Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells
-
Pawelec G, Ehninger G, Rehbein A, Schaudt K, Jaschonek K. Comparison of the immunosuppressive activities of the antimycotic agents itraconazole, fluconazole, ketoconazole and miconazole on human T-cells. Int. J. Immunopharmacol. 13(2-3), 299-304 (1991)
-
(1991)
Int. J. Immunopharmacol.
, vol.13
, Issue.2-3
, pp. 299-304
-
-
Pawelec, G.1
Ehninger, G.2
Rehbein, A.3
Schaudt, K.4
Jaschonek, K.5
-
37
-
-
0028219757
-
The effects of itraconazole on the immune responses in ICR mice
-
Kim JH, Ahn YK. The effects of itraconazole on the immune responses in ICR mice. J. Toxicol. Sci. 19(1), 7-15 (1994)
-
(1994)
J. Toxicol. Sci.
, vol.19
, Issue.1
, pp. 7-15
-
-
Kim, J.H.1
Ahn, Y.K.2
-
38
-
-
0035671298
-
Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis
-
Kanda N, Enomoto U, Watanabe S. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis. J. Invest. Dermatol. 117(6), 1635-1646 (2001)
-
(2001)
J. Invest. Dermatol.
, vol.117
, Issue.6
, pp. 1635-1646
-
-
Kanda, N.1
Enomoto, U.2
Watanabe, S.3
-
39
-
-
33646133898
-
Itraconazole suppresses an elicitation phase of a contact hypersensitivity reaction
-
Ausaneya U, Kawada A, Aragane Y. Itraconazole suppresses an elicitation phase of a contact hypersensitivity reaction. J. Invest. Dermatol. 126(5), 1028-1035 (2006)
-
(2006)
J. Invest. Dermatol.
, vol.126
, Issue.5
, pp. 1028-1035
-
-
Ausaneya, U.1
Kawada, A.2
Aragane, Y.3
-
40
-
-
33847633030
-
Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus
-
Simitsopoulou M, Roilides E, Likartsis C et al. Expression of immunomodulatory genes in human monocytes induced by voriconazole in the presence of Aspergillus fumigatus. Antimicrob. Agents Chemother. 51(3), 1048-1054 (2007)
-
(2007)
Antimicrob. Agents Chemother.
, vol.51
, Issue.3
, pp. 1048-1054
-
-
Simitsopoulou, M.1
Roilides, E.2
Likartsis, C.3
-
41
-
-
0031660264
-
Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole
-
Varis T, Kaukonen KM, Kivisto KT, Neuvonen PJ. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole. Clin. Pharmacol. Ther. 64(4), 363-368 (1998)
-
(1998)
Clin. Pharmacol. Ther.
, vol.64
, Issue.4
, pp. 363-368
-
-
Varis, T.1
Kaukonen, K.M.2
Kivisto, K.T.3
Neuvonen, P.J.4
-
42
-
-
0034071745
-
The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone
-
Varis T, Kivisto KT, Neuvonen PJ. The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone. Eur. J. Clin. Pharmacol. 56(1), 57-60 (2000)
-
(2000)
Eur. J. Clin. Pharmacol.
, vol.56
, Issue.1
, pp. 57-60
-
-
Varis, T.1
Kivisto, K.T.2
Neuvonen, P.J.3
-
43
-
-
0035989387
-
Iatrogenic adrenal insufficiency as a side effect of combined treatment of itraconazole and budesonide
-
Skov M, Main KM, Sillesen IB, Muller J, Koch C, Lanng S. Iatrogenic adrenal insufficiency as a side effect of combined treatment of itraconazole and budesonide. Eur. Respir. J. 20(1), 127-133 (2002)
-
(2002)
Eur. Respir. J.
, vol.20
, Issue.1
, pp. 127-133
-
-
Skov, M.1
Main, K.M.2
Sillesen, I.B.3
Muller, J.4
Koch, C.5
Lanng, S.6
-
44
-
-
0023121793
-
Trial of ketoconazole in non-invasive pulmonary aspergillosis
-
Shale DJ, Faux JA, Lane DJ. Trial of ketoconazole in non-invasive pulmonary aspergillosis. Thorax 42(1), 26-31 (1987)
-
(1987)
Thorax
, vol.42
, Issue.1
, pp. 26-31
-
-
Shale, D.J.1
Faux, J.A.2
Lane, D.J.3
-
45
-
-
0023429550
-
Trial of ketoconazole in allergic bronchopulmonary aspergillosis
-
Fournier EC. Trial of ketoconazole in allergic bronchopulmonary aspergillosis. Thorax 42(10), 831 (1987)
-
(1987)
Thorax
, vol.42
, Issue.10
, pp. 831
-
-
Fournier, E.C.1
-
46
-
-
0025367019
-
Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis
-
Currie DC, Lueck C, Milburn HJ et al. Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis. Thorax 45(6), 447-450 (1990)
-
(1990)
Thorax
, vol.45
, Issue.6
, pp. 447-450
-
-
Currie, D.C.1
Lueck, C.2
Milburn, H.J.3
-
47
-
-
0032881833
-
Treatment of late-onset asthma with fluconazole
-
3 Pt 1
-
Ward GW Jr, Woodfolk JA, Hayden ML, Jackson S, Platts-Mills TA. Treatment of late-onset asthma with fluconazole. J. Allergy Clin. Immunol. 104(3 Pt 1), 541-546 (1999)
-
(1999)
J. Allergy Clin. Immunol.
, vol.104
, pp. 541-546
-
-
Ward Jr., G.W.1
Woodfolk, J.A.2
Hayden, M.L.3
Jackson, S.4
Platts-Mills, T.A.5
-
48
-
-
2342565781
-
Treatment of allergic bronchopulmonary aspergillosis with fluconazole and itraconazole
-
Rai SP, Panda BN, Bhargava S. Treatment of allergic bronchopulmonary aspergillosis with fluconazole and itraconazole. Med. J. Armed Forces India 60(2), 128-130 (2004)
-
(2004)
Med. J. Armed Forces India
, vol.60
, Issue.2
, pp. 128-130
-
-
Rai, S.P.1
Panda, B.N.2
Bhargava, S.3
-
49
-
-
29544437697
-
Voriconazole therapy in children with cystic fibrosis
-
Hilliard T, Edwards S, Buchdahl R et al. Voriconazole therapy in children with cystic fibrosis. J. Cyst. Fibros. 4(4), 215-220 (2005)
-
(2005)
J. Cyst. Fibros.
, vol.4
, Issue.4
, pp. 215-220
-
-
Hilliard, T.1
Edwards, S.2
Buchdahl, R.3
-
50
-
-
65349170114
-
Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis
-
Glackin L, Leen G, Elnazir B, Greally P. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. Ir. Med. J. 102(1), 29 (2009)
-
(2009)
Ir. Med. J.
, vol.102
, Issue.1
, pp. 29
-
-
Glackin, L.1
Leen, G.2
Elnazir, B.3
Greally, P.4
-
51
-
-
70350482636
-
The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis
-
Pasqualotto AC, Powell G, Niven R, Denning DW. The effects of antifungal therapy on severe asthma with fungal sensitization and allergic bronchopulmonary aspergillosis. Respirology 14(8), 1121-1127 (2009)
-
(2009)
Respirology
, vol.14
, Issue.8
, pp. 1121-1127
-
-
Pasqualotto, A.C.1
Powell, G.2
Niven, R.3
Denning, D.W.4
-
52
-
-
0021128347
-
Itraconazole, a new triazole that is orally active in aspergillosis
-
Van Cutsem J, Van Gerven F, Van de Ven MA, Borgers M, Janssen PA. Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob. Agents Chemother. 26(4), 527-534 (1984)
-
(1984)
Antimicrob. Agents Chemother.
, vol.26
, Issue.4
, pp. 527-534
-
-
Van Cutsem, J.1
Van Gerven, F.2
Van De Ven, M.A.3
Borgers, M.4
Janssen, P.A.5
-
54
-
-
84856074224
-
High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole
-
Burgel PR, Baixench MT, Amsellem M et al. High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole. Antimicrob. Agents Chemother. 56(2), 869-874 (2012)
-
(2012)
Antimicrob. Agents Chemother.
, vol.56
, Issue.2
, pp. 869-874
-
-
Burgel, P.R.1
Baixench, M.T.2
Amsellem, M.3
-
55
-
-
46249109837
-
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus
-
Rodriguez-Tudela JL, Alcazar-Fuoli L, Mellado E, Alastruey-Izquierdo A, Monzon A, Cuenca-Estrella M. Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus. Antimicrob. Agents Chemother. 52(7), 2468-2472 (2008)
-
(2008)
Antimicrob. Agents Chemother.
, vol.52
, Issue.7
, pp. 2468-2472
-
-
Rodriguez-Tudela, J.L.1
Alcazar-Fuoli, L.2
Mellado, E.3
Alastruey-Izquierdo, A.4
Monzon, A.5
Cuenca-Estrella, M.6
-
56
-
-
77649245725
-
Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis
-
Agarwal R, Khan A, Aggarwal AN, Gupta D. Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis. Monaldi Arch. Chest Dis. 71(4), 161-169 (2009)
-
(2009)
Monaldi Arch. Chest Dis.
, vol.71
, Issue.4
, pp. 161-169
-
-
Agarwal, R.1
Khan, A.2
Aggarwal, A.N.3
Gupta, D.4
|